万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://journals.lww.com/jhypertension/pages/default.aspx
3、投稿网址：http://www.editorialmanager.com/jh/
4、官网邮箱：info@jhypertens.com（主编）
jofhypertension@gmail.com（总编）
5、期刊刊期：月刊，一年出版12期。
2021年8月10日星期二
投稿须知【官网信息】
Guidance for Authors on the Preparation and Submission of Manuscripts to Journal of Hypertension
These instructions comply with those formulated by the International Committee of Medical Journal Editors. For further details, authors should consult the following article: International Committee of Medical Journal Editors, “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals" at www.icmje.org.
The Journal is a member of the Committee on Publication Ethics (COPE) which aims to define best practice in the ethics of scientific publishing. COPE has established a number of guidelines as part of a set of Core Practices (www.publicationethics.org).
Appeals on editorial decisions should be sent to the Editor. Complaints related to how your paper was processed during peer-review and not resolved by the Editor, should be referred to the person named as publisher in "About the Journal" under "Journal Info" contacts (http://journals.lww.com/jhypertension/Pages/aboutthejournal.aspx) or if unsatisfied to COPE (www.publicationethics.org).
Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editor and those invited to do so from the board and reviewer pool.
This Journal allows authors to choose an Open Access option for their published article on payment of a fee. See the Open Access section below.
SCOPE
The Journal of Hypertension publishes papers reporting original clinical and experimental research which are of a high standard and which contribute to the advancement of knowledge in the field of hypertension. The Journal publishes full papers, reviews or editorials (normally by invitation), and correspondence.
SUBMISSIONS
Authors can submit their manuscripts through the web-based tracking system at http://www.editorialmanager.com/jh. Authors should submit the text of the paper as a word-processed document, and not as a PDF. The site contains instructions and advice on how to use the system. Authors should NOT post a hard copy submission to the editorial office, unless you have been instructed to do so. All submitted manuscripts should be addressed to the Editor-in-Chief, Giuseppe Mancia.
Margins should be not less than 3 cm. Double spacing should be used throughout the manuscript, which should include the following sections, each starting on a separate page: title page, abstract and keywords, text, acknowledgements, references, individual tables and captions. Pages should be numbered consecutively, beginning with the title page, and the page number should be placed in the top right-hand corner of each page. Abbreviations should be defined on their first appearance in the text; those not accepted by international bodies should be avoided.
Article Types
Original manuscripts (Original clinical and experimental research)
Reviews (These also include Systematic Reviews and Meta-analyses)
Editorials and Editorial Comments (By invitation)
Consensus Documents and Guidelines (By agreement between Scientific Societies and the Editor)
Case reports (Unusual single cases or series of cases with a learning point or significant contribution to understanding of hypertension)
Correspondence (Mostly, brief comments on published papers and authors' replies)
ESH News (Submitted by the Scientific Society)
ISH News (Submitted by the Scientific Society)
All manuscripts should be as concise as possible, with the number of Tables and Figures not exceeding those required for scientific information. The Editor may require reduction of length and illustrations, whenever convenient and will communicate this as necessary. Case Report should be no more than 2000 words, excluding abstract (150 words), references (maximum 20), tables and figures (maximum 3 in total). Correspondence should be limited to 800 words and one illustration (figure or table).
Non-native speakers of English: Authors who are not native speakers of English and require help in writing an article in English are encouraged to seek assistance from a qualified colleague or consider using a language service in preparing a manuscript submission. Wolters Kluwer, in partnership with Editage, offers such services - for more information please visit http://wkauthorservices.editage.com. Please note that the use of this or other services are at the author's own expense and risk, and independent from the editorial processes of this journal, and does not guarantee that an article will be accepted for publication.
POINTS TO CONSIDER WHEN SUBMITTING YOUR PAPER TO ONE OF OUR JOURNALS
Please think carefully about the following points and make the appropriate declarations.
Redundant or duplicate publication, and Preprints
Submissions are accepted on the understanding that they have not been published in their current form or a substantially similar form (in print or electronically, including on a web site), that they have not been accepted for publication elsewhere, and they are not under consideration by another publication.
Preprints: Work posted on a preprint server, which identifies a preprint as not peer-reviewed, will be considered for publication. The author should declare preprint server deposition on submitting their article to the Journal. If the article is accepted, to ensure readers can find and cite the final published version, authors should add the Digital Object Identifier (DOI) of the published journal article to the posted preprint version.
Conflicts of interest
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:”. For example:
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.
Copyright: In addition, each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors, (www.icmje.org/update.html).
A copy of the form is made available to the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with instructions on completing the form upon submission.
Permissions to reproduce previously published material
Authors must obtain prior permission to reproduce material (such as illustrations) from the copyright holder. The granting of permission should be acknowledged alongside the material (e.g., within legend of a figure) in the submitted article. Authors are responsible for paying any fees to reproduce material.
Subject consent
Subjects have a right to privacy that should not be infringed without informed consent. Informed consent should be obtained from patients or other subjects of experiments that clearly grants permission for the publication of photographs or other material that might identify them. If the consent form for your research did not specifically include this, please obtain it or remove the identifying material. Identifying details (written or photographic) should be omitted if they are not essential, but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. When informed consent has been obtained it should be indicated in the submitted article.
Ethics committee approval
The Editors reserve the right to judge the appropriateness of the use and treatment of humans or animals in experiments for publication in the journal.
Human experiments: All work must be conducted in accordance with the Declaration of Helsinki. Papers describing experimental work on human participants which carries a risk of harm must include (1) a statement that the experiments were conducted with the understanding and the consent of each participant, and (2) a statement that the responsible ethical committee has approved the experiments.
Animal experiments: In papers describing experiments on living animals, include (1) a full description of any anaesthetic and surgical procedure used, and (2) evidence that all possible steps were taken to avoid animals’ suffering at each stage of the experiment.
Experiments on isolated tissues: Indicate precisely how you obtained the donor tissue.
Systematic Reviews and Meta-analysis
Authors should follow the PRISMA guidelines (www.prisma-statement.org) on reporting items for systematic reviews and meta-analyses. Such reviews often serve as a basis for many health policy decisions and direction for further research, and following these guidelines will assist in improving the quality of reports available.
Clinical Trials, Data Sharing and Behavioural and Public Health Evaluations
Authors reporting results of randomised controlled trials should include with their submission a complete checklist from the CONSORT statement (www.consort-statement.org). For behavioural and public health evaluations involving non-randomised designs, authors should include with their submission a complete checklist from the TREND statement (www.cdc.gov/trendstatement/).
Registration of clinical trials: As a condition for publication of a clinical trial in the Journal, registration of the trial in a public registry is required. The editor does not advocate one particular registry but require that the registry utilised meet the criteria set out in the statement of policy of the ICMJE (www.icmje.org).
Clinical trial papers must contain a data sharing statement on whether data is available or not as outlined in the ICMJE policy (www.icmje.org). A data sharing plan must be included in a trial's registration for those that begin enrolling participants on or after 1 January 2019. Authors of secondary analyses using shared data must reference the source of the data and attest their use was in accordance with any terms agreed.
Authorship
All authors must meet the criteria for authorship as established by the International Committee of Medical Journal Editors, that they believe that the paper represents honest work, and that they are able to verify the validity of the results reported.
In the case of a large study group involvement, please list the names of authors that meet the ICMJE criteria on the title page of the paper and include a study group name, if required, to encompass other author contributors. The study group name on the title page should be marked with a superscript asterisk, with a footnote on the title page stating "*A list of other author contributors are listed in the Acknowledgment section." Clearly identify in the Acknowledgement section those individuals who meet the author criteria after a superscript asterisk and study group name and the text "author contributors:". Other study sites and participants should be identified and listed separately to this study group.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Copyright assignment
Papers are accepted for publication on the understanding that exclusive copyright in the paper is assigned to the Publisher. Authors are asked to submit a signed copyright assignment form with their submission. They may use material from their paper in other works published by them after seeking formal permission.
……
更多详情：
https://edmgr.ovid.com/jh/accounts/ifauth.htm
